Zymeworks Return on Investment 2016-2022 | ZYME
Current and historical return on investment (ROI) values for Zymeworks (ZYME) over the last 10 years.
| Zymeworks ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2022-06-30 |
$-0.24B |
|
inf% |
| 2022-03-31 |
$-0.24B |
|
inf% |
| 2021-12-31 |
$-0.22B |
|
inf% |
| 2021-09-30 |
$-0.21B |
|
inf% |
| 2021-06-30 |
$-0.23B |
|
inf% |
| 2021-03-31 |
$-0.20B |
|
inf% |
| 2020-12-31 |
$-0.19B |
|
inf% |
| 2020-09-30 |
$-0.22B |
|
inf% |
| 2020-06-30 |
$-0.18B |
|
inf% |
| 2020-03-31 |
$-0.17B |
|
inf% |
| 2019-12-31 |
$-0.15B |
|
inf% |
| 2019-09-30 |
$-0.07B |
|
inf% |
| 2019-06-30 |
$-0.06B |
|
inf% |
| 2019-03-31 |
$-0.03B |
|
inf% |
| 2018-12-31 |
$-0.03B |
|
inf% |
| 2018-09-30 |
$-0.01B |
|
inf% |
| 2018-06-30 |
$-0.01B |
|
inf% |
| 2018-03-31 |
$-0.01B |
|
inf% |
| 2017-12-31 |
$-0.01B |
|
-66.67% |
| 2017-09-30 |
$-0.05B |
|
-168.25% |
| 2017-06-30 |
$-0.05B |
|
-149.21% |
| 2017-03-31 |
$-0.05B |
$0.05B |
-142.86% |
| 2016-12-31 |
$-0.04B |
$0.07B |
-216.67% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.570B |
$0.412B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
